|
1
|
The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study.
|
Am J Clin Nutr
|
2004
|
1.82
|
|
2
|
Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease.
|
Gastroenterology
|
2010
|
1.73
|
|
3
|
CD8+ cytotoxic T cells induce relapsing colitis in normal mice.
|
Gastroenterology
|
2006
|
1.47
|
|
4
|
A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization.
|
Am J Gastroenterol
|
2010
|
1.22
|
|
5
|
Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases.
|
Inflamm Bowel Dis
|
2011
|
1.07
|
|
6
|
Irritable bowel syndrome in France: a common, debilitating and costly disorder.
|
Eur J Gastroenterol Hepatol
|
2004
|
1.06
|
|
7
|
Small bowel adenocarcinoma in patients with Crohn's disease compared with small bowel adenocarcinoma de novo.
|
Inflamm Bowel Dis
|
2005
|
1.03
|
|
8
|
Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
|
Inflamm Bowel Dis
|
2013
|
1.00
|
|
9
|
Management for severe Crohn's disease: a lifetime cost-utility analysis.
|
Int J Technol Assess Health Care
|
2004
|
0.94
|
|
10
|
Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis.
|
Inflamm Bowel Dis
|
2007
|
0.93
|
|
11
|
Infliximab treatment does not induce organ-specific or nonorgan-specific autoantibodies other than antinuclear and anti-double-stranded DNA autoantibodies in Crohn's disease.
|
Inflamm Bowel Dis
|
2005
|
0.89
|
|
12
|
Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2012
|
0.88
|
|
13
|
Tumor necrosis factor alpha reduces butyrate oxidation in vitro in human colonic mucosa: a link from inflammatory process to mucosal damage?
|
Inflamm Bowel Dis
|
2005
|
0.88
|
|
14
|
Butyrate strongly inhibits in vitro stimulated release of cytokines in blood.
|
Dig Dis Sci
|
2002
|
0.86
|
|
15
|
Transcutaneous posterior tibial nerve stimulation for fecal incontinence in inflammatory bowel disease patients: a therapeutic option?
|
Inflamm Bowel Dis
|
2009
|
0.84
|
|
16
|
CD4+ T cells and Lactobacillus casei control relapsing colitis mediated by CD8+ T cells.
|
J Immunol
|
2009
|
0.84
|
|
17
|
Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease.
|
Inflamm Bowel Dis
|
2015
|
0.82
|
|
18
|
Laparoscopic total colectomy: Does the indication influence the outcome?
|
World J Gastrointest Surg
|
2011
|
0.78
|
|
19
|
[Recommendations for clinical practice for the treatment of ulcerative colitis].
|
Gastroenterol Clin Biol
|
2004
|
0.77
|
|
20
|
Gastrointestinal tolerance to an inulin-rich soluble roasted chicory extract after consumption in healthy subjects.
|
Nutrition
|
2010
|
0.76
|
|
21
|
Gut Inflammation in Mice Triggers Proliferation and Function of Mucosal Foxp3+ Regulatory T Cells but Impairs Their Conversion from CD4+ T Cells.
|
J Crohns Colitis
|
2016
|
0.76
|
|
22
|
"Comment on a retraction": author response.
|
Am J Gastroenterol
|
2009
|
0.75
|
|
23
|
Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease.
|
Inflamm Bowel Dis
|
2017
|
0.75
|
|
24
|
[Chronic active ulcerative colitis. Efficacy of intravenous followed by oral cyclosporine combined with azathioprine].
|
Presse Med
|
2004
|
0.75
|
|
25
|
[Segmentary infarct of the greater omentum: a rare cause of acute abdomen].
|
Gastroenterol Clin Biol
|
2003
|
0.75
|
|
26
|
A positive breath hydrogen test does not predict the occurrence of a spontaneous bacterial peritonitis in cirrhotic patients with ascites.
|
Digestion
|
2009
|
0.75
|
|
27
|
[Pancytopenia induced by two low-dose injections of methotrexate in a patient treated for ulcerative colitis].
|
Gastroenterol Clin Biol
|
2007
|
0.75
|
|
28
|
[Practical forms for the use of the main drugs in the treatment of ulcerative colitis].
|
Gastroenterol Clin Biol
|
2004
|
0.75
|
|
29
|
Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study.
|
Inflamm Bowel Dis
|
2017
|
0.75
|
|
30
|
Sugar intolerance: origin and mechanisms of symptoms?
|
Dig Dis Sci
|
2002
|
0.75
|
|
31
|
Is scintigraphic double-track appearance a sign of severe acute episodes of ulcerative colitis?
|
Gastroenterol Clin Biol
|
2004
|
0.75
|
|
32
|
[Recommendations for clinical practice for the treatment of ulcerative colitis: general method].
|
Gastroenterol Clin Biol
|
2004
|
0.75
|
|
33
|
Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years.
|
Inflamm Bowel Dis
|
2016
|
0.75
|
|
34
|
[Introduction of the evidence].
|
Gastroenterol Clin Biol
|
2004
|
0.75
|
|
35
|
[Ulcerative colitis and anti-TNFalpha].
|
Gastroenterol Clin Biol
|
2007
|
0.75
|